This calculation is straightforward, but patients consistently underestimate how quickly they will move through vials as doses escalate
The Medicare GLP-1 Bridge Program lets eligible Medicare Part D beneficiaries get Wegovy, Zepbound, or Foundayo for a $50 per month medication copay from July 1, 2026 through December 31, 2027
But over time, I found myself asking a different one: if this medication helps me lose weight, keeps it off, protects my heart, and improves my blood sugar, and it is safe for me, why would I stop
8,9 GLP-1 agonists also upregulate keratinocyte migration due to P13K/Akt activation, which is pertinent to wound healing
The medication can offer some benefits for patients who have had their gallbladders removed, as well as people who struggle with weight loss in general
This unwelcome guest can make us skip doses, and that messes up our chances to keep shedding pounds